The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Innate or Adaptive Immunity? The Example of Natural Killer Cells
Open accessAbstract
Natural killer (NK) cells were originally defined as effector lymphocytes of innate immunity endowed with constitutive cytolytic functions. More recently, a more nuanced view of NK cells has emerged. NK cells are now recognized to express a repertoire of activating and inhibitory receptors that is calibrated to ensure self-tolerance while allowing efficacy against assaults such as viral infection and tumor development. Moreover, NK cells do not react in an invariant manner but rather adapt to their environment. Finally, recent studies have unveiled that NK cells can also mount a form of antigen-specific immunologic memory. NK cells thus exert sophisticated biological functions that are attributes of both innate and adaptive immunity, blurring the functional borders between these two arms of the immune response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Depending on the ligands expressed by the tumor cells studied, different NK-activating receptors may be engaged and trigger cytotoxicity (Vivier et al., 2011).”
From p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells (2013) · cites this paper as Vivier et al., 2011
In the citing paper
“Further analysis showed that the translocation of E. hirae to secondary lymphoid organs could exert an adjuvant impact on systemic and local immune responses mediated by CTX [2].”
From Gut microbiota-mediated immunomodulation in tumor (2021) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., Posati, S., Rogaia, D., Frassoni, F., Aversa, F., et al. (2002) · Science · doi:10.1126/science.1068440 · Cited by 3,380
Lanier, L. L. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,765
Self-citationSelective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
Kärre, K., Ljunggren, H., Piontek, G., & Kiessling, R. (1986) · Nature · doi:10.1038/319675a0 · Cited by 2,333
Caligiuri, M. A. (2008) · Blood · doi:10.1182/blood-2007-09-077438 · Cited by 1,980
Self-citationMiller, J. S., Soignier, Y., Panoskaltsis‐Mortari, A., McNearney, S. A., Yun, G. H., Fautsch, S. K., McKenna, D. H., Le, C. T., DeFor, T. E., Burns, L. J., et al. (2005) · Blood · doi:10.1182/blood-2004-07-2974 · Cited by 1,894
Kiessling, R. W., Klein, E., & Wigzell, H. (1975) · European Journal of Immunology · doi:10.1002/eji.1830050208 · Cited by 1,827
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R., & Moretta, L. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.197 · Cited by 1,773
Self-citationAdaptive Immune Features of Natural Killer Cells
Sun, J. C., Beilke, J., & Lanier, L. (2009) · Nature · doi:10.1038/nature07665 · Cited by 1,647
Self-citationHerberman, R. B., Nunn, M. E., & Lavrin, D. H. (1975) · International Journal of Cancer · doi:10.1002/ijc.2910160204 · Cited by 1,356
Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming
Martin‐Fontecha, A., Thomsen, L. L., Brett, S. J., Gerard, C. J., Lipp, M., Lanzavecchia, A., & Sallusto, F. (2004) · Nature Immunology · doi:10.1038/ni1138 · Cited by 1,351
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 1,003
Martin, M. P., & Carrington, M. N. (2013) · Immunological Reviews · doi:10.1111/imr.12071 · Cited by 152
Natural killer cells regulate diverse T cell responses
Crome, S. Q., Lang, P. A., Lang, K. S., & Ohashi, P. S. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.03.002 · Cited by 151
Matta, J., Baratin, M., Chiche, L., Forel, J.-M., Cognet, C., Thomas, G., Farnarier, C., Pipéroglou, C., Papazian, L., Chaussabel, D., et al. (2013) · Blood · doi:10.1182/blood-2013-01-481705 · Cited by 151
Self-citationCAR-NK Cells: From Natural Basis to Design for Kill
Khawar, M. B., & Sun, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.707542 · Cited by 164
Mikulak, J., Bruni, E., Oriolo, F., Di Vito, C., & Mavilio, D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00946 · Cited by 145
The Emerging Functions of Long Noncoding RNA in Immune Cells: Autoimmune Diseases
Sigdel, K. R., Cheng, A., Wang, Y., Duan, L., & Zhang, Y. (2015) · Journal of Immunology Research · doi:10.1155/2015/848790 · Cited by 150
The split nature of tumor-infiltrating leukocytes
Lança, T., & Silva‐Santos, B. (2012) · OncoImmunology · doi:10.4161/onci.20068 · Cited by 154
Ahlenstiel, G., Edlich, B., Hogdal, L. J., Rotman, Y., Noureddin, M., Feld, J. J., Holz, L. E., Titerence, R. H., Liang, T. J., & Rehermann, B. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.069 · Cited by 150
Role of Distinct Natural Killer Cell Subsets in Anticancer Response
Stabile, H., Fionda, C., Gismondi, A., & Santoni, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00293 · Cited by 149
Natural Killer Cells Degenerate Intact Sensory Afferents following Nerve Injury
Davies, A. J., Kim, H. W., González‐Cano, R., Choi, J., Back, S. K., Roh, S. E., Johnson, E., Gabriac, M., Kim, M.-S., Lee, J., et al. (2019) · Cell · doi:10.1016/j.cell.2018.12.022 · Cited by 153
Self-citationEvolution of Vertebrate Immunity
Boehm, T. L. J. (2012) · Current Biology · doi:10.1016/j.cub.2012.07.003 · Cited by 150
Parodi, M., Raggi, F., Cangelosi, D., Manzini, C., Balsamo, M., Blengio, F., Eva, A., Varesio, L., Pietra, G., Moretta, L., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02358 · Cited by 147
Crinier, A., Dumas, P., Escalière, B., Pipéroglou, C., Gil, L., Villacreces, A., Vely, F., Ivanović, Z., Milpied, P. J., Narni-Mancinelli, É., et al. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00574-8 · Cited by 147
Viant, C., Fenis, A., Chicanne, G., Payrastre, B., Ugolini, S., & Vivier, É. (2014) · Nature Communications · doi:10.1038/ncomms6108 · Cited by 155
Self-citationMarkers and function of human NK cells in normal and pathological conditions
Zotto, G. D., Marcenaro, E., Vacca, P., Sivori, S., Pende, D., Chiesa, M. D., Moretta, F., Ingegnere, T., Mingari, M. C., Moretta, A., et al. (2017) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.21508 · Cited by 148
Self-citationLocatelli, F., Pende, D., Falco, M., Chiesa, M. D., Moretta, A., & Moretta, L. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.04.009 · Cited by 149
Self-citationWitek Janusek, L., Tell, D., & Mathews, H. L. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.04.012 · Cited by 143
Cottineau, J., Kottemann, M. C., Lach, F. P., Kang, Y., Vely, F., Deenick, E. K., Lazarov, T., Gineau, L., Wang, Y., Farina, A., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90727 · Cited by 143
Confinement of Activating Receptors at the Plasma Membrane Controls Natural Killer Cell Tolerance
Guia, S., Jaeger, B. N., Piatek, S., Mailfert, S., Trombik, T., Fenis, A., Chevrier, N., Walzer, T., Kerdiles, Y. M., Marguet, D., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001608 · Cited by 140
Self-citationCrooke, S. N., Ovsyannikova, I. G., Poland, G. A., & Kennedy, R. B. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110632 · Cited by 146
Ramirez, K., Chandler, K. J., Spaulding, C., Zandi, S., Sigvardsson, M., Graves, B. J., & Kee, B. L. (2012) · Immunity · doi:10.1016/j.immuni.2012.04.006 · Cited by 142
Lee, S. S., & Cheah, Y. K. (2019) · Journal of Immunology Research · doi:10.1155/2019/3046379 · Cited by 142
Flower isoforms promote competitive growth in cancer
Madan, E., Pelham, C. J., Nagane, M., Parker, T. M., Canas‐Marques, R., Fazio, K., Shaik, K., Yuan, Y., Henriques, V., Galzerano, A., et al. (2019) · Nature · doi:10.1038/s41586-019-1429-3 · Cited by 146
Human Natural Killer Cells: Origin, Receptors, Function, and Clinical Applications
Moretta, L., Montaldo, E., Vacca, P., Zotto, G. D., Moretta, F., Merli, P., Locatelli, F., & Mingari, M. C. (2014) · International Archives of Allergy and Immunology · doi:10.1159/000365632 · Cited by 142
Sánchez-Correa, B., Morgado, S., Gayoso, I., Bergua, J., Casado, J. G., Arcos, M. J., Bengochea, M. L., Durán, E., Solana, R., & Tarazona, R. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1050-2 · Cited by 145
Hill, B. S., Sarnella, A., D’Avino, G., & Zannetti, A. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.028 · Cited by 142
Immunological memory within the innate immune system
Sun, J. C.-Y., Ugolini, S., & Vivier, É. (2014) · The EMBO Journal · doi:10.1002/embj.201387651 · Cited by 139
Self-citationZhang, T., Wu, M.-R., & Sentman, C. L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103495 · Cited by 140
Tumour microenvironment responsive nanoconstructs for cancer theranostic
Gulzar, A., Xu, J., Wang, C., He, F., Yang, D., Gai, S., Yang, P., Lin, J., Jin, D., & Xing, B. (2019) · Nano Today · doi:10.1016/j.nantod.2019.03.007 · Cited by 141
Choi, I., Yoon, S. R., Park, S.-Y., Kim, H., Jung, S.-J., Jang, Y. J., Kang, M., Yeom, Y. I., Lee, J., Kim, D., et al. (2014) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2014.01.031 · Cited by 136
Pahl, J. H. W., Koch, J., Götz, J.-J., Arnold, A., Reusch, U., Gantke, T., Rajkovic, E., Treder, M., & Cerwenka, A. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0550 · Cited by 137
ARID5B regulates metabolic programming in human adaptive NK cells
Cichocki, F. M., Wu, C., Zhang, B., Felices, M., Tesi, B., Tuininga, K., Dougherty, P., Taras, E., Hinderlie, P., Blazar, B. R., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20172168 · Cited by 131
Pembrolizumab plus allogeneic NK cells in advanced non–small cell lung cancer patients
Lin, M., Luo, H., Liang, S., Chen, J., Liu, A., Niu, L., & Jiang, Y. (2020) · Journal of Clinical Investigation · doi:10.1172/jci132712 · Cited by 141
Galectin-9 Functionally Impairs Natural Killer Cells in Humans and Mice
Golden‐Mason, L., McMahan, R. H., Strong, M., Reisdorph, R. M., Mahaffey, S. B., Palmer, B. E., Cheng, L., Kulesza, C. A., Hirashima, M., Niki, T., et al. (2013) · Journal of Virology · doi:10.1128/jvi.01085-12 · Cited by 137
Bioinspired self-healing materials: lessons from nature
Cremaldi, J. C., & Bhushan, B. (2018) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.9.85 · Cited by 143
Unleashing Natural Killer Cells in the Tumor Microenvironment–The Next Generation of Immunotherapy?
Ben‐Shmuel, A., Biber, G., & Barda‐Saad, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00275 · Cited by 138
NK Cell-Depleting Anti-Asialo GM1 Antibody Exhibits a Lethal Off-Target Effect on Basophils In Vivo
Nishikado, H., Mukai, K., Kawano, Y., Minegishi, Y., & Karasuyama, H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100370 · Cited by 135
Cell death-based treatments of melanoma:conventional treatments and new therapeutic strategies
Mattia, G., Puglisi, R., Ascione, B., Malorni, W., Carè, A., & Matarrese, P. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0059-7 · Cited by 139
Muntasell, A., Vilches, C., Angulo, A., & López‐Botet, M. (2013) · European Journal of Immunology · doi:10.1002/eji.201243117 · Cited by 132
Complement factor P is a ligand for the natural killer cell–activating receptor NKp46
Narni-Mancinelli, É., Gauthier, L., Baratin, M., Guia, S., Fenis, A., Deghmane, A., Rossi, B., Fourquet, P., Escalière, B., Kerdiles, Y. M., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aam9628 · Cited by 144
Self-citationSomanchi, S. S., Somanchi, A., Cooper, L. J. N., & Lee, D. A. (2012) · Blood · doi:10.1182/blood-2011-11-389924 · Cited by 135
CAR-T Cell Therapy for Breast Cancer: From Basic Research to Clinical Application
Yang, Y.-H., Liu, J., Lu, C., & Wei, J. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.70120 · Cited by 135
Li, J., Ren, H., Qiu, Q., Yang, X., Zhang, J., Zhang, C., Sun, B., Lovell, J. F., & Zhang, Y. (2022) · ACS Nano · doi:10.1021/acsnano.2c06926 · Cited by 131
Nrf2 Induces IL-17D to Mediate Tumor and Virus Surveillance
Saddawi-Konefka, R., Seelige, R., Gross, E. T. E., Levy, E., Searles, S. C., Washington, A., Santosa, E. K., Liu, B., O’Sullivan, T. E., Harismendy, O., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.075 · Cited by 126
Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE
Van Kaer, L., Postoak, J. L., Wang, C., Yang, G., & Wu, L. (2019) · Cellular & Molecular Immunology · doi:10.1038/s41423-019-0221-5 · Cited by 148
CDK8-Mediated STAT1-S727 Phosphorylation Restrains NK Cell Cytotoxicity and Tumor Surveillance
Putz, E. M., Gotthardt, D., Hoermann, G., Csiszar, A., Wirth, S., Berger, A., Straka, E., Rigler, D., Wallner, B., Jamieson, A. M., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.07.012 · Cited by 132
Lei, L., Huang, D., Gao, H., He, B., Cao, J., & Peppas, N. A. (2022) · Science Advances · doi:10.1126/sciadv.adc8738 · Cited by 134
Dietary Supplements and Nutraceuticals under Investigation for COVID-19 Prevention and Treatment
Lordan, R., Rando, H. M., & Greene, C. S. (2021) · mSystems · doi:10.1128/msystems.00122-21 · Cited by 137
Diversity of immune strategies explained by adaptation to pathogen statistics
Mayer, A., Mora, T., Rivoire, O., & Walczak, A. M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600663113 · Cited by 137
Juliá, E. P., Amante, A., Pampena, M. B., Mordoh, J., & Levy, E. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02140 · Cited by 135
Wang, G., Hu, W., Chen, H., Shou, X., Ye, T., & Xu, Y. (2019) · Cancers · doi:10.3390/cancers11101560 · Cited by 129
Differential Location and Distribution of Hepatic Immune Cells
Freitas-Lopes, M., Mafra, K., David, B., Carvalho-Gontijo, R., & Menezes, G. (2017) · Cells · doi:10.3390/cells6040048 · Cited by 126
Victorino, F., Sojka, D. K., Brodsky, K. S., McNamee, E. N., Masterson, J. C., Homann, D., Yokoyama, W. M., Eltzschig, H. K., & Clambey, E. T. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500651 · Cited by 128
Self-citationTargeting Natural Killer Cells for Tumor Immunotherapy
Zhang, C., Hu, Y., & Shi, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00060 · Cited by 128
Liu, H., Tang, L. Y., Li, Y., Xie, W., Zhang, L., Tang, H., Xiao, T., Yang, H., Gu, W., Wang, H., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-023-01928-2 · Cited by 140
Canter, R. J., Grossenbacher, S. K., Foltz, J. A., Sturgill, I. R., Park, J. S., Luna, J. I., Kent, M. S., Culp, W. T. N., Chen, M., Modiano, J. F., et al. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0305-7 · Cited by 131
You, F., Wang, Y., Jiang, L., Zhu, X., Chen, D., Yuan, L., An, G., Meng, H., & Yang, L. (2019) · Europe PMC (PubMed Central) · Cited by 127
Characterization of tumor infiltrating Natural Killer cell subset
Levi, I., Amsalem, H., Nissan, A., Darash‐Yahana, M., Peretz, T., Mandelboim, O., & Rachmilewitz, J. (2015) · Oncotarget · doi:10.18632/oncotarget.3453 · Cited by 131
A mathematical model for pancreatic cancer growth and treatments
Louzoun, Y., Xue, C., Lesinski, G. B., & Friedman, A. (2014) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2014.02.028 · Cited by 126
NAKAYAMA, M., Takeda, K., Kawano, M., Takai, T., Ishii, N., & Ogasawara, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110584108 · Cited by 137
Natural Killer Cell Response to Chemotherapy-Stressed Cancer Cells: Role in Tumor Immunosurveillance
Zingoni, A., Fionda, C., Borrelli, C., Cippitelli, M., Santoni, A., & Soriani, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01194 · Cited by 126
Targeting T cell malignancies using CAR-based immunotherapy: challenges and potential solutions
Fleischer, L. C., Spencer, H. T., & Raikar, S. S. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0801-y · Cited by 127
Immunological memory: What's in a name?
Pradeu, T., & Pasquier, L. D. (2018) · Immunological Reviews · doi:10.1111/imr.12652 · Cited by 135
Overview of recent advances in liposomal nanoparticle-based cancer immunotherapy
Gao, A., Hu, X., Saeed, M., Chen, B., Li, Y., & Yu, H. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0281-1 · Cited by 125
CEACAM1 structure and function in immunity and its therapeutic implications
Kim, W. M., Huang, Y., Gandhi, A. K., & Blumberg, R. S. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.101296 · Cited by 127
Prins, R. M., Wang, X., Soto, H., Young, E., Lisiero, D. N., Fong, B., Everson, R. G., Yong, W. H., Lai, A., Li, G., et al. (2013) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3182811ae4 · Cited by 124
Morandi, B., Mortara, L., Chiossone, L., Accolla, R. S., Mingari, M. C., Moretta, L., Moretta, A., & Ferlazzo, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039170 · Cited by 124
Self-citationMechanisms of tumor escape from immune system: Role of mesenchymal stromal cells
Poggi, A. D., Musso, A., Dapino, I., & Zocchi, M. R. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.03.001 · Cited by 126
Ratajczak, W., Niedźwiedzka‐Rystwej, P., Tokarz–Deptuła, B., & Deptuła, W. (2018) · Central European Journal of Immunology · doi:10.5114/ceji.2018.77390 · Cited by 121
Gestational Diabetes Mellitus and Maternal Immune Dysregulation: What We Know So Far
McElwain, C. J., McCarthy, F. P., & McCarthy, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084261 · Cited by 134
Advances in NK cell production
Fang, F., Xie, S., Chen, M., Li, Y., Yue, J., Ma, J., Shu, X., He, Y., Xiao, W., & Tian, Z. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00808-3 · Cited by 132
Use of NK cell activity in cure by transplant
Leung, W. H. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08823.x · Cited by 122
Natural killer cells in HIV-1 infection and therapy
Mikulak, J., Oriolo, F., Zaghi, E., Vito, C. D., & Mavilio, D. (2017) · AIDS · doi:10.1097/qad.0000000000001645 · Cited by 124
Redgrove, K. A., & McLaughlin, E. A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00534 · Cited by 132
Chong, H.-X., Yusoff, N. A. A., Hor, Y.-Y., Lew, L.-C., Jaafar, M. H., Choi, S. B., Yusoff, M. S. B., Wahid, N. A., Abdullah, M. F. I. L. B., Zakaria, N., et al. (2019) · Journal of Dairy Science · doi:10.3168/jds.2018-16103 · Cited by 121
Reigniting hope in cancer treatment: the promise and pitfalls of IL-2 and IL-2R targeting strategies
Muhammad, S., Fan, T. T., Hai, Y., Gao, Y., & He, J. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01826-7 · Cited by 130
Meazza, R., Azzarone, B. G., Orengo, A. M., & Ferrini, S. (2011) · BioMed Research International · doi:10.1155/2011/861920 · Cited by 117
Genetics, genomics, and evolutionary biology of NKG 2D ligands
Carapito, R., & Bahram, S. (2015) · Immunological Reviews · doi:10.1111/imr.12328 · Cited by 125
Early natural killer cell counts in blood predict mortality in severe sepsis
Andaluz‐Ojeda, D., Iglesias, V., Bobillo, F., Almansa, R., Rico, L., Gandía, F., Loma, A. M., Nieto, C., Diego, R., Ramos, E., et al. (2011) · Critical Care · doi:10.1186/cc10501 · Cited by 123
ITPR1 Protects Renal Cancer Cells against Natural Killer Cells by Inducing Autophagy
Messai, Y., Noman, M. Z., Hasmim, M., Janji, B., Tittarelli, A., Boutet, M., Baud, V., Viry, E., Billot, K., Nanbakhsh, A., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0303 · Cited by 119
Neural stem cells sustain natural killer cells that dictate recovery from brain inflammation
Liu, Q., Sanai, N., Jin, W., Cava, A. L., Kaer, L. V., & Shi, F. (2016) · Nature Neuroscience · doi:10.1038/nn.4211 · Cited by 119
The up side of decidual natural killer cells: new developments in immunology of pregnancy
Jabrane‐Ferrat, N., & Siewiera, J. (2013) · Immunology · doi:10.1111/imm.12218 · Cited by 128
Han, B., Mao, F.-Y., Zhao, Y., Lv, Y.-P., Teng, Y., Duan, M., Chen, W., Cheng, P., Wang, T., Liang, Z.-Y., et al. (2018) · Journal of Immunology Research · doi:10.1155/2018/6248590 · Cited by 126
A Randomized Placebo-Controlled Trial of Massage Therapy on the Immune System of Preterm Infants
Ang, J. Y., Lua, J. L., Mathur, A., Thomas, R. G., Asmar, B. I., Savaşan, S., Buck, S. A., Long, M., & Shankaran, S. (2012) · PEDIATRICS · doi:10.1542/peds.2012-0196 · Cited by 120
CEACAM1 as a Multi-Purpose Target for Cancer Immunotherapy
Dankner, M., Gray‐Owen, S. D., Huang, Y., Blumberg, R. S., & Beauchemin, N. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1328336 · Cited by 118
Mancusi, A., Ruggeri, L., Urbani, E., Pierini, A., Massei, M. S., Carotti, A., Terenzi, A., Falzetti, F., Tosti, A., Topini, F., et al. (2015) · Blood · doi:10.1182/blood-2014-09-599993 · Cited by 114
Li, T., Yi, S., Liu, W., Jia, C., Wang, G., Hua, X., Tai, Y., Zhang, Q., & Chen, G. (2013) · Medical Oncology · doi:10.1007/s12032-013-0663-z · Cited by 120
Leukocyte trafficking in tumor microenvironment
Prete, A. D., Schioppa, T., Tiberio, L., Stabile, H., & Sozzani, S. (2017) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2017.05.004 · Cited by 122
Immune Response in Neurological Pathology: Emerging Role of Central and Peripheral Immune Crosstalk
Passaro, A. P., Lebos, A. L., Yao, Y., & Stice, S. L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.676621 · Cited by 124
Annexin A1 as a Regulator of Immune Response in Cancer
Araújo, T. G., Mota, S. T. S., Ferreira, H. S. V., Ribeiro, M. A., Goulart, L. R., & Vecchi, L. (2021) · Cells · doi:10.3390/cells10092245 · Cited by 116
Cheng, M. L., Nakib, D., Perciani, C. T., & MacParland, S. A. (2021) · Clinical Science · doi:10.1042/cs20190654 · Cited by 130
Dondero, A., Pastorino, F., Chiesa, M. D., Corrias, M. V., Morandi, F., Pistoia, V., Olive, D., Bellora, F., Locatelli, F., Castellano, A., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1064578 · Cited by 113
Self-citationPeripheral immunity is associated with the risk of incident dementia
Zhang, Y.-R., Wang, J.-J., Chen, S.-F., Wang, H.-F., Li, Y.-Z., Ou, Y.-N., Huang, S.-Y., Chen, S.-D., Cheng, W., Feng, J.-F., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01446-5 · Cited by 114
López‐Botet, M., Muntasell, A., & Vilches, C. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.03.002 · Cited by 117
Regulatory NK cells in autoimmune disease
Tian, Z., Gershwin, M. E., & Zhang, C. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.05.006 · Cited by 116
The role of the inflammatory microenvironment in thyroid carcinogenesis
Cunha, L. L., Marcello, M. A., & Ward, L. S. (2013) · Endocrine Related Cancer · doi:10.1530/erc-13-0431 · Cited by 114
Natural killer cell immunotherapies against cancer: checkpoint inhibitors and more
Chiossone, L., Vienne, M., Kerdiles, Y. M., & Vivier, É. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.08.003 · Cited by 120
METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer
García-Vílchez, R., Añazco-Guenkova, A. M., Dietmann, S., López, J., Morón-Calvente, V., D’Ambrosi, S., Nombela, P., Zamacola, K., Mendizabal, I., Garcia‐Longarte, S., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01809-8 · Cited by 118
Gut microbiota-mediated immunomodulation in tumor
Liu, X., Chen, Y., Zhang, S., & Dong, L. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01983-x · Cited by 112
Qian, G., Tang, L., Guo, X., Wang, F., Massey, M. E., Su, J., Guo, T. L., Williams, J. H., Phillips, T. D., & Wang, J. (2013) · Journal of Applied Toxicology · doi:10.1002/jat.2866 · Cited by 112
Metadata
- Authors
- Vivier, E., Raulet, D. H., Moretta, A., Caligiuri, M. A., Zitvogel, L., Lanier, L. L., Yokoyama, W. M., & Ugolini, S.
- Affiliations
- Centre d’Immunologie de Marseille-Luminy (CIML), Université de la Méditerranée UM 631, Campus de Luminy, 13288 Marseille, France.
- University of California, Berkeley (US)
- University of Genoa (IT)
- The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (US)
- Inserm (FR)
- University of California, San Francisco (US)
- Howard Hughes Medical Institute (US)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Raulet, David H.
- Moretta, Alessandro
- Caligiuri, Michael A.
- Zitvogel, Laurence
- Lanier, Lewis L.
- Yokoyama, Wayne M.
- Ugolini, Sophie
- ORCID
- Venue
- Science
- Published
- 2011-01-07
- Volume
- 331
- Issue
- 6013
- Pages
- 44-49
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3089969
- OpenAlex
- W2146313292
- Cited by
- 2,824
- References
- 78
- Citations by year
- 2026: 133 · 2025: 147 · 2024: 158 · 2023: 142 · 2022: 215 · 2021: 211 · 2020: 222 · 2019: 205 · 2018: 176 · 2017: 211 · 2016: 176 · 2015: 191 · 2014: 199 · 2013: 200 · 2012: 150
- FWCI
- 17.62
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Cancer Institute (R01CA093678, R01CA095137, P01CA095426, CA095137, CA16058, CA 68458, CA95426, CA093678, P30CA016058)
- National Institute of Allergy and Infectious Diseases (AI-068129, R01AI068129, AI51345, R37AI066897, AI039642, AI34385, R01AI033903, AI5716, R01AI051345, AI-33903, R01AI039642, AI066897, R01AI035021, AI035021, P30AI027763)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- natural killer cells, innate immunity, adaptive immunity, NK cell receptors, activating and inhibitory receptors, self-tolerance, cytotoxicity, viral infection, antitumor immunity, immunological memory
- MeSH terms
- Animals, Humans, Immunity, Innate, Immunologic Memory, Killer Cells, Natural, Neoplasms, Receptors, Immunologic, Virus Diseases, Self Tolerance, Adaptive Immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
